PLx Pharma Inc. Reports Second Quarter 2018 Results

Q2-2019 Revenues of $1.0 million compared to $0.3 million in Q2-2018 H1-2019 Revenues of $2.8 million compared to $0.5 million in H1-2018 Strong pre-launch interest and pr.....»»

– Company Completes Successful $15 Million Financing – HOUSTON, March 08, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company initially focused on developing its cli.....»»

Recro Pharma Reports First Quarter 2018 Financial Results.....»»

MEI Pharma Reports Third Quarter Fiscal Y.....»»

HOUSTON, May 11, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceu.....»»

NDA submission for Gimotiâ„¢ on track for second quarter of 2018 Announced.....»»

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fisc.....»»

Intec Pharma Reports First Quarter 2018 Financial Results and Corporate Update More than 350 patients enrolled in pivotal Phase 3 A.....»»

- Continued.....»»

CONSHOHOCKEN, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Madrigal Pharma.....»»

ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2018 Results and Updates Guidance Acquires WellSpring Pharma Services for $18 Million in Cash to Expand Contract Manufacturing Business and Accelerate ANDA Pipeline .....»»

HOUSTON, Aug. 10, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on c.....»»

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fisca.....»»

Intec Pharma Reports Second Quarter 2018 Financial Results and Corporate Update Enrolled more than 95% of .....»»

- Continued advancement of endocrinology rare disease pipeline, paving way for application of TransCo.....»»

PLx has identified the alternate supply of a key ingredient for Vazalore HOUSTON, Nov. 09, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on commerciali.....»»

HAIKOU CITY, China, Nov. 15, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE:CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with a fully.....»»

Ascendis Pharma A/S Reports Third Quarter 2018 Financial Results.....»»

HOUSTON, TX and VANCOUVER, Dec. 13, 2018 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSXV:EPI, NASDAQ:EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corpo.....»»

HOUSTON, TX and VANCOUVER, Feb. 7, 2019 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSXV:EPI, NASDAQ:EPIX), a pharmaceutical company focused on developin.....»»